Here are the S-3 shelf registrations from My Size, Inc (MYSZ) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow MYSZ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MYSZ filings page.
My Size, Inc. (MYSZ) filed a shelf registration statement covering potential offerings of up to $100,000,000 in aggregate initial offering price across common stock, debt securities, warrants and units. The company may conduct one or more offerings after the registration statement becomes effective; specific terms will be provided in the applicable prospectus supplement.
My Size currently intends to use net proceeds for working capital, repayment of trade payables and general corporate purposes. It also announced an acquisition-led growth strategy focused on evaluating potential acquisitions to build a defense technology platform, diversifying beyond its fashion technology and commerce operations.
My Size, Inc. (MYSZ) registers for resale up to 4,018,326 shares of common stock issuable upon warrant exercise; selling stockholders may not sell until the registration statement is effective. My Size will receive no proceeds from resale sales, but may receive proceeds from cash warrant exercises; if all referenced warrants are exercised for cash in full, proceeds would be approximately $4.57 million. Net proceeds from any such exercises are intended for general corporate purposes and working capital. The private placement closed September 16, 2026, with approximately $2.5 million in gross proceeds.
On September 14, 2026, the company announced an acquisition-led strategy to evaluate and potentially acquire defense technology businesses, subject to suitable targets, due diligence, definitive agreements, financing and required approvals. The audit report on its 2025 financial statements cites significant losses, negative operating cash flows and an accumulated deficit that raise substantial doubt about its ability to continue as a going concern.